Release Date: 29/10/21 08:22 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 747.11KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%